Pharmacodynamic Analysis of a Serine Protease Inhibitor, MK-4519, Against Hepatitis C Virus Using a Novel in Vitro Pharmacodynamic System
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.05383-11
Full Text
Open PDFAbstract
Available in full text
Date
December 12, 2011
Authors
Publisher
American Society for Microbiology